Price target
3.500.000.00%
The 2 analysts offering 1 year price forecasts for VRCA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to VRCA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
VRCA EPS for the last quarter is −0.49 USD despite the estimation of −0.38 USD. In the next quarter EPS is expected to reach −0.30 USD. Track more of Verrica Pharmaceuticals Inc. financials and stay on top of what is up with the company.
In the next quarter Verrica Pharmaceuticals Inc. revenue is expected to reach 532.75 K USD. Check out Verrica Pharmaceuticals Inc. revenue and earnings and make informed decisions.
According to analysts, VRCA price target is 3.50 USD with a max estimate of 5.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Verrica Pharmaceuticals Inc. stock price chart and keep track of the current situation with VRCA news and stock market news.
We've gathered opinions of 5 analysts rating VRCA stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.